GR1001028B - Ανυδρο υγρο αιωρημα με βαση ελαια για την αποδοση ενος φαρμακου. - Google Patents
Ανυδρο υγρο αιωρημα με βαση ελαια για την αποδοση ενος φαρμακου.Info
- Publication number
- GR1001028B GR1001028B GR900100441A GR900100441A GR1001028B GR 1001028 B GR1001028 B GR 1001028B GR 900100441 A GR900100441 A GR 900100441A GR 900100441 A GR900100441 A GR 900100441A GR 1001028 B GR1001028 B GR 1001028B
- Authority
- GR
- Greece
- Prior art keywords
- liquid suspension
- medicament
- delivering
- based liquid
- anhydrous oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36540989A | 1989-06-13 | 1989-06-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
GR900100441A GR900100441A (en) | 1991-11-15 |
GR1001028B true GR1001028B (el) | 1993-03-31 |
Family
ID=23438802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR900100441A GR1001028B (el) | 1989-06-13 | 1990-06-13 | Ανυδρο υγρο αιωρημα με βαση ελαια για την αποδοση ενος φαρμακου. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0477289A4 (ja) |
JP (1) | JPH04506216A (ja) |
KR (1) | KR920702616A (ja) |
AU (1) | AU639004B2 (ja) |
CA (1) | CA2060501A1 (ja) |
GR (1) | GR1001028B (ja) |
IE (1) | IE902109A1 (ja) |
IL (1) | IL94710A (ja) |
PT (1) | PT94372A (ja) |
WO (1) | WO1991008734A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
JP2001240534A (ja) * | 2000-02-29 | 2001-09-04 | Bio Kagaku Kk | 液状組成物 |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
US20040202696A1 (en) * | 2003-04-14 | 2004-10-14 | Cts Chemical Industries Ltd. | Administration form for veterinary use |
WO2006008640A1 (en) * | 2004-07-15 | 2006-01-26 | Pharmacia & Upjohn Company Llc | Non-aqueous suspension containing a drug having an unpleasant taste |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2238973A (en) * | 1940-07-26 | 1941-04-22 | American Cyanamid Co | Sulphonamide compound in oil |
US2951014A (en) * | 1957-01-03 | 1960-08-30 | Upjohn Co | Process for a stable oil suspension |
US2867565A (en) * | 1957-08-12 | 1959-01-06 | Feinstone Wolffe Harry | Sulfonamide composition comprising a lipid-aqueous emulsion carrier |
US3996355A (en) * | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
US4684666A (en) * | 1986-08-19 | 1987-08-04 | Haas Pharmaceuticals, Inc. | Stabilized liquid analgesic compositions |
IE59934B1 (en) * | 1987-06-19 | 1994-05-04 | Elan Corp Plc | Liquid suspension for oral administration |
IL87219A0 (en) * | 1987-08-07 | 1988-12-30 | Abbott Lab | Erythromycin formulations for oral administration |
IL87483A (en) * | 1987-09-14 | 1993-07-08 | Abbott Lab | Anhydrous oil-based liquid suspension for delivering clorazepate dipotassium or estazolam |
-
1990
- 1990-06-08 JP JP2510223A patent/JPH04506216A/ja active Pending
- 1990-06-08 CA CA002060501A patent/CA2060501A1/en not_active Abandoned
- 1990-06-08 AU AU59342/90A patent/AU639004B2/en not_active Ceased
- 1990-06-08 EP EP19900910225 patent/EP0477289A4/en not_active Withdrawn
- 1990-06-08 WO PCT/US1990/003250 patent/WO1991008734A1/en not_active Application Discontinuation
- 1990-06-08 KR KR1019910701847A patent/KR920702616A/ko not_active Application Discontinuation
- 1990-06-12 IE IE210990A patent/IE902109A1/en unknown
- 1990-06-12 IL IL9471090A patent/IL94710A/en not_active IP Right Cessation
- 1990-06-12 PT PT94372A patent/PT94372A/pt not_active Application Discontinuation
- 1990-06-13 GR GR900100441A patent/GR1001028B/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0477289A4 (en) | 1992-07-22 |
CA2060501A1 (en) | 1990-12-14 |
AU5934290A (en) | 1991-07-18 |
IL94710A (en) | 1995-05-26 |
JPH04506216A (ja) | 1992-10-29 |
IE902109L (en) | 1990-12-13 |
WO1991008734A1 (en) | 1991-06-27 |
AU639004B2 (en) | 1993-07-15 |
KR920702616A (ko) | 1992-10-06 |
IE902109A1 (en) | 1991-01-02 |
IL94710A0 (en) | 1991-04-15 |
EP0477289A1 (en) | 1992-04-01 |
PT94372A (pt) | 1991-02-08 |
GR900100441A (en) | 1991-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4824669A (en) | Formulations of coenzyme Q10 for intravenous use | |
FR2611203B1 (fr) | Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent | |
EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
IT8721668A0 (it) | Insufflatore per la somministrazione di farmaci sottoforma di polvere predosata in opercoli. | |
HUP9802339A2 (hu) | Darifenacint tartalmazó gyógyászati készítmények | |
TW224428B (ja) | ||
HUP0003583A2 (hu) | Ibuprofen tartalmú gyógyászati szerek | |
KR100211192B1 (ko) | 메지스트롤 아세테이트 제제 | |
NZ501950A (en) | Medicinal compositions for application to mucosa | |
MA21264A1 (fr) | Composition permettant d'administrer un medicament sous forme de gellules, d'une poudre ou d'un liquide. | |
ATE98119T1 (de) | Stabile wasserfreie zusammensetzung zur topischen abgabe von aktiven materialien. | |
FI891570A0 (fi) | Menetelmä piroksikaamia sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
ATE133423T1 (de) | Rekonstituierte hdl-teilchen und ihre verwendung | |
GR1001028B (el) | Ανυδρο υγρο αιωρημα με βαση ελαια για την αποδοση ενος φαρμακου. | |
ES2062610T3 (es) | Compuesto diarilico anti-ateroesclerotico. | |
IT8720129A0 (it) | Composizioni farmaceutiche sottoforma di sospensioni stabili di sucralfato esenti da agenti sospendenti. | |
Ferrell et al. | The interrelation of neural discharge, intra‐articular pressure, and joint angle in the knee of the dog. | |
MC1969A1 (fr) | Procedes pour preparer des composes antitumoraux,formulation pharmaceutique contenant ces composes,leurs utilisations en medecine et pharmacie,et composes intermediaires pour leur preparation | |
FI943103A0 (fi) | Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi | |
US6255308B1 (en) | Treatment of equine protozoal myeloencephalitis | |
DE3263832D1 (en) | Gallium chloride, an anti-cancer drug | |
WO2003053403A3 (en) | Pharmaceutical suspension for oral administration | |
FR2611497B1 (fr) | Agglomerats, leur preparation et compositions pharmaceutiques et/ou cosmetiques les contenant | |
DE60032372D1 (de) | Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen | |
Moolenaar et al. | Biopharmaceutics of rectal administration of drugs in man 7. Absorption rate and bioavailability of phenobarbital and its sodium salt from rectal dosage forms |